This preliminary program is subject to change.

Advances in Cell Culture I


Description:
This session intends to cover current development and progress in insect, mammalian, and plant cell culture. Topics welcomed for this session include, but are not limited to, optimizing cell culture performance using metabolomics, development of high throughput cell culture screening system, optimization of cell production by transfecting transgene via designed vectors, characterization of bioreactor operating environments at both small and large scales, improvements in animal-free media for therapeutic protein production, optimizing yield of cell-culture-based products, advances in cell culture process development for the production of biofuels, vaccines, and stem cells.

Sponsor:
Bioengineering


Chair:
Kumar Dhanasekharan
Principal Process Engineer/ Scientist
Genzyme Corporation
Bioprocess Engineering, Technology Development
45 New York Ave
Framingham, MA 01701
Phone Number: 508-271-2864
Email: kumar.dhanasekharan@genzyme.com

Co-Chair:
Ching-An Peng

Papers:
Engineering Gene Expression Dynamics of Mammalian Cells in Culture
Huong Le, University of Minnesota; Inseok Doo, University of Minnesota; Anne Kantardjieff, University of Minnesota; Wei-Shou Hu, University of Minnesota
13C Flux Analysis of CHO Cell Metabolism Over Entire Cell Culture Phase for Recombinant Protein Production
Neelanjan Sengupta, Purdue University; John A. Morgan, Purdue University
Characterization and Application of Noninvasive Optical Sensors for Online pH and Dissolved Oxygen Monitoring in Mammalian Shake Flask Cultures
Jennifer L. Autsen, Genentech, Inc; Jun Luo, Genentech, Inc; Wen-Lin Tsai, Genentech, Inc; Sofia P. Rebelo, Genentech, Inc; Judy H. Chou, Genentech, Inc
Growth and Productivity of NS0 Cells with Nanoparticle Cholesterol Supplementation
Yun Wu, The Ohio State University; Jeffrey J. Chalmers, The Ohio State University; Barbara E. Wyslouzil, The Ohio State University; L. James Lee, The Ohio State University; Susan Casnocha, Global Biologics, Pfizer, Inc.; Ellen L. McCormick, Global Biologics, Pfizer, Inc.; Ningning Ma, Global Biologics, Pfizer, Inc.
Cell Damage of Human and Industrial Cell Lines in Bioprocess Equipment
Claudia Berdugo, The Ohio State University; Serra Elliott, The Ohio State University; Jeffrey J. Chalmers, The Ohio State University
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division